Development of a Risk-Screening Tool for Cancer Survivors to Participate in Unsupervised Moderate-to Vigorous-Intensity Exercise: Results From a Survey Study

被引:12
作者
Brown, Justin C. [1 ]
Ko, Emily M. [1 ]
Schmitz, Kathryn H. [1 ]
机构
[1] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA
关键词
PRIMARY-CARE PHYSICIANS; ALL-CAUSE MORTALITY; BREAST-CANCER; AMERICAN-COLLEGE; SPORTS-MEDICINE; UPDATED RECOMMENDATION; PUBLIC-HEALTH; FOLLOW-UP; WOMEN; REHABILITATION;
D O I
10.1016/j.pmrj.2014.09.003
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Background: The health benefits of exercise increase in dose-response fashion among cancer survivors. However, it is unclear how to identify cancer survivors who may require a pre-exercise evaluation before they progress from the common recommendation of walking to unsupervised moderate-to vigorous-intensity exercise. Objective: To clarify how to identify cancer survivors who should undergo a pre-exercise evaluation before they progress from the common recommendation of walking to unsupervised moderate-to vigorous-intensity exercise. Design: Electronic survey. Participants: Forty-seven (n = 47) experts in the field of exercise physiology, rehabilitation medicine, and cancer survivorship. Setting: Not applicable. Methods: We synthesized peer-reviewed guidelines for exercise and cancer survivorship and identified 82 health factors that may warrant a pre-exercise evaluation before a survivor engages in unsupervised moderate-to vigorous-intensity exercise. The 82 health factors were classified into 3 domains: (1) clinical health factors; (2) comorbidity and device health factors; and (3) medications. We surveyed a sample of experts asking them to identify which of the 82 health factors among cancer survivors would indicate the need for a pre-exercise evaluation before they engaged in moderate-to vigorous-intensity exercise. Main Outcome Measurements: The response rate to our survey was 75% (n = 47). Across the 3 domains of health factors, acute symptoms, comorbidities, and medications related to cardiovascular disease were agreed on to indicate a pre-exercise evaluation for survivors before they engaged in unsupervised moderate-to vigorous-intensity exercise. Other health factors in the survey included hematologic, musculoskeletal, systemic, gastrointestinal, pulmonary, and neurological symptoms and comorbidities. Eighteen experts (38%) said it was difficult to provide absolute answers because no 2 patients are alike, and their decisions are made on a case-by-case basis. Conclusions: The results from this expert survey will help to identify which cancer survivors should undergo a pre-exercise evaluation before they engage in unsupervised moderate-to vigorous-intensity exercise.
引用
收藏
页码:113 / 122
页数:10
相关论文
共 64 条
[1]   Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: randomised controlled trial [J].
Adamsen, Lis ;
Quist, Morten ;
Andersen, Christina ;
Moller, Tom ;
Herrstedt, Jorn ;
Kronborg, Dorte ;
Baadsgaard, Marie T. ;
Vistisen, Kirsten ;
Midtgaard, Julie ;
Christiansen, Birgitte ;
Stage, Maria ;
Kronborg, Morten T. ;
Rorth, Mikael .
BMJ-BRITISH MEDICAL JOURNAL, 2009, 339 :895-898
[2]   Physical Activity Guidelines Advisory Committee Report, 2008 [J].
不详 .
NUTRITION REVIEWS, 2009, 67 (02) :114-120
[3]  
[Anonymous], ACSMS GUIDE EXERCISE
[4]  
Baechle T.R., 2008, Resistance training. Essentials of strength and conditioning, P381
[5]   Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins [J].
Baigent, C ;
Keech, A ;
Kearney, PM ;
Blackwell, L ;
Buck, G ;
Pollicino, C ;
Kirby, A ;
Sourjina, T ;
Peto, R ;
Collins, R ;
Simes, J .
LANCET, 2005, 366 (9493) :1267-1278
[6]   PHYSICAL-FITNESS AND ALL-CAUSE MORTALITY - A PROSPECTIVE-STUDY OF HEALTHY-MEN AND WOMEN [J].
BLAIR, SN ;
KOHL, HW ;
PAFFENBARGER, RS ;
CLARK, DG ;
COOPER, KH ;
GIBBONS, LW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 262 (17) :2395-2401
[7]   Malignancies, prothrombotic mutations, and the risk of venous thrombosis [J].
Blom, JW ;
Doggen, CJM ;
Osanto, S ;
Rosendaal, FR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 293 (06) :715-722
[8]   Safety of Weightlifting Among Women with or at Risk for Breast Cancer-Related Lymphedema: Musculoskeletal Injuries and Health Care Use in a Weightlifting Rehabilitation Trial [J].
Brown, Justin C. ;
Troxel, Andrea B. ;
Schmitz, Kathryn H. .
ONCOLOGIST, 2012, 17 (08) :1120-1128
[9]  
Brown JC, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030955, 10.1371/journal.pone.0036735]
[10]  
Campbell KL, 2012, BRIT J SPORT MED, V46, P909, DOI [10.1136/bjsports-2010-082719, 10.1136/bjsm.2010.082719]